Life After Martin Shkreli — A Conversation With Turing … – Forbes – Forbes


Forbes
Life After Martin Shkreli — A Conversation With Turing … – Forbes
Forbes
When asked what it is like to tell people that be runs Turing’s R&D, Salinas admits it’s difficult. After all, this company is the poster child for pharmaceutical¬†…

and more >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd